185 related articles for article (PubMed ID: 35313390)
21. Thrombotic thrombocytopenic purpura (TTP) after COVID-19 vaccination: A systematic review of reported cases.
Saluja P; Gautam N; Yadala S; Venkata AN
Thromb Res; 2022 Jun; 214():115-121. PubMed ID: 35533526
[TBL] [Abstract][Full Text] [Related]
22. Safety of anti-SARS-CoV-2 vaccination for patients with immune thrombocytopenia.
Crickx E; Moulis G; Ebbo M; Terriou L; Briantais A; Languille L; Limal N; Guillet S; Michel M; Mahevas M; Godeau B
Br J Haematol; 2021 Dec; 195(5):703-705. PubMed ID: 34467525
[No Abstract] [Full Text] [Related]
23. Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination.
Fueyo-Rodriguez O; Valente-Acosta B; Jimenez-Soto R; Neme-Yunes Y; Inclán-Alarcón SI; Trejo-Gonzalez R; García-Salcido MÁ
BMJ Case Rep; 2021 May; 14(5):. PubMed ID: 34059544
[TBL] [Abstract][Full Text] [Related]
24. Successful mRNA SARS-Cov-2 vaccine rechallenge after a first episode of immune thrombocytopenic purpura.
Chanut M; Jaidi R; Kohn M; Grange T; Brones C; Lombion N; Rousselot P; Longval T
Platelets; 2022 May; 33(4):652-653. PubMed ID: 35225144
[TBL] [Abstract][Full Text] [Related]
25. Severe case of refractory immune thrombocytopenic purpura requiring splenectomy after the COVID-19 vaccine.
Koilpillai S; Dominguez B; Khan A; Carlan S
BMJ Case Rep; 2022 Jun; 15(6):. PubMed ID: 35725277
[TBL] [Abstract][Full Text] [Related]
26. Relapse of immune thrombotic thrombocytopenic purpura (iTTP) possibly triggered by COVID-19 vaccination and/or concurrent COVID-19 infection.
Fang F; Tse B; Pavenski K
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35902184
[TBL] [Abstract][Full Text] [Related]
27. Immune thrombocytopenic purpura secondary to SARS-CoV-2 infection in a child with acute lymphoblastic leukaemia: a case report and review of literature.
Dongre A; Jameel PZ; Deshmukh M; Bhandarkar S
BMJ Case Rep; 2021 Nov; 14(11):. PubMed ID: 34740909
[TBL] [Abstract][Full Text] [Related]
28. Immune thrombocytopenia in the setting of acute SARS-CoV-2 infection.
Caseiro Alves ME; Carmo F; Malato M; Cunha F
BMJ Case Rep; 2023 Jun; 16(6):. PubMed ID: 37385718
[TBL] [Abstract][Full Text] [Related]
29. Uncommon thrombotic complications after SARS-CoV-2 vaccination.
Musil D
Vnitr Lek; 2021; 67(5):297-302. PubMed ID: 35459396
[TBL] [Abstract][Full Text] [Related]
30. Acute immune thrombocytopenia following SARS-CoV-2 vaccination in chronic ITP patients and a healthy individual.
Ogai A; Yoshida R; Yuasa C; Chin K; Fujimaki K; Nakajima H
Int J Hematol; 2022 Feb; 115(2):293-295. PubMed ID: 34716890
[No Abstract] [Full Text] [Related]
31. Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia.
Mori A; Onozawa M; Kobayashi M; Tsukamoto S; Senjo H; Ishio T; Yokoyama E; Izumiyama K; Saito M; Muraki H; Morioka M; Teshima T; Kondo T
Br J Haematol; 2023 Mar; 200(6):717-721. PubMed ID: 36442510
[TBL] [Abstract][Full Text] [Related]
32. Safety of SARS-CoV2 vaccination and COVID-19 short-term outcome in pediatric acquired demyelinating disorders of central nervous system: A single center experience.
Monte G; Papetti L; Ferilli MAN; Ursitti F; Moavero R; Sforza G; Panella E; Tarantino S; Checchi MP; Vigevano F; Palma P; Valeriani M
Front Immunol; 2023; 14():1106472. PubMed ID: 36761740
[TBL] [Abstract][Full Text] [Related]
33. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
Akova M; Unal S
Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
[TBL] [Abstract][Full Text] [Related]
34. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.
Perry RJ; Tamborska A; Singh B; Craven B; Marigold R; Arthur-Farraj P; Yeo JM; Zhang L; Hassan-Smith G; Jones M; Hutchcroft C; Hobson E; Warcel D; White D; Ferdinand P; Webb A; Solomon T; Scully M; Werring DJ; Roffe C;
Lancet; 2021 Sep; 398(10306):1147-1156. PubMed ID: 34370972
[TBL] [Abstract][Full Text] [Related]
35. Vigilance regarding immune thrombocytopenic purpura after COVID-19 vaccine.
Saudagar V; Patil S; Goh S; Pothiawala S
Ir J Med Sci; 2022 Apr; 191(2):919-920. PubMed ID: 33788135
[TBL] [Abstract][Full Text] [Related]
36. Platelet dropping, bleeding and new treatment requirements in ITP patients after inactivated COVID-19 vaccination.
Zhan XY; Chen H; Kong H; Meng T; Ye J; Liu Y; Ng MHL; Li L; Zhang Y; Huang J; Peng Q; Chen C; He Y; Yang M
Immunol Lett; 2023 Dec; 264():56-63. PubMed ID: 38006954
[TBL] [Abstract][Full Text] [Related]
37. Protective effects of COVID-19 vaccination in splenectomized patients with immune thrombocytopenia.
Liu X; Gan X; Xu J; Wang Y; Huang J; He X; Li Y; Gong Y; Peng B; Niu T
Br J Haematol; 2024 Jun; 204(6):2217-2221. PubMed ID: 38632670
[TBL] [Abstract][Full Text] [Related]
38. Simultaneous Occurrence of Immune-Mediated Thrombocytopenia and Myocarditis After mRNA-1273 COVID-19 Vaccination: A Case Report.
Bae DH; Kim M; Lee DI; Lee JH; Kim S; Lee SY; Bae JW; Hwang KK; Kim DW; Cho MC
J Korean Med Sci; 2022 May; 37(21):e169. PubMed ID: 35638196
[TBL] [Abstract][Full Text] [Related]
39. Relapses of Immune Thrombocytopenia after the Second and Booster Doses of BNT162b2 Vaccine.
Ratajczak-Enselme M; Mutoni GC; Desmeules J; Favet L; Ing Lorenzini K
Acta Haematol; 2023; 146(1):52-57. PubMed ID: 36327915
[TBL] [Abstract][Full Text] [Related]
40. Severe Immune Thrombocytopenia after COVID-19 Vaccination: Two Case Reports and a Literature Review.
Shonai T; Kimura F; Watanabe J
Intern Med; 2022 May; 61(10):1581-1585. PubMed ID: 35314552
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
